J&J to buy Micrus for $480m
Johnson & Johnson will buy Micrus Endovascular for $480m (£319.8m) to expand its portfolio of medical devices that treat and prevent strokes, the companies said yesterday. J&J will pay $23.40 a share, a 5.5 per cent premium over Micrus’ closing price on Friday. Micrus’ shares have climbed 50 per cent this year.